Engineered immune cells unleashed to fight devastating autoimmune diseases
NCT ID NCT06347718
Summary
This early-stage trial is testing a new cell therapy for adults with severe, hard-to-treat autoimmune diseases like lupus, scleroderma, and muscle inflammation diseases. Doctors take a patient's own immune T-cells, genetically modify them to hunt and destroy harmful B-cells that drive the disease, and then infuse them back. The main goal is to see if this approach is safe, while also checking if it helps control these serious conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universitätsklinikum Erlangen
RECRUITINGErlangen, Bavaria, 91054, Germany
Contact
Contact
Conditions
Explore the condition pages connected to this study.